BRINGING OBJECTIVITY AND PRECISION TO PAIN MANAGEMENT

 

ABOUT ALGOMETRX

our_vision_edited.png
OUR TECHNOLOGY

The AlgometRx Nociometer® enables a fundamental paradigm shift in pain assessment and analgesic prescribing. Our novel technology and algorithms analyze pupil dilation in response to neuroselective stimulation to formulate a nociceptive profile. This new construct is used to characterize pain type, intensity and assess the pharmacodynamic impact of analgesics. This transformative platform technology can be applied to any population.

 

OUR TEAM

Julia Finkel, MD
Founder & Chief Scientific Advisor
Kevin Jackson
Product Engineer
David Gross, MSEE
Chariman, Board of Directors
David Heller, MBA
Board of Directors

OUR ADVISORS

Susan_edited.png
Susan Alpert, PhD, MD
Regulatory Expert
Misha_edited.png
Misha Backonja, MD
Neurologist and Clinical Trial Expert
Irving_edited.png
Irving McConnell, DVM
Veterinarian
Marilyn_edited.png
Marilyn Huestis, PhD
Pharmacologist/
Toxicologist

OUR COLLABORATORS

CNH logo.png
GWU Logo.png
NCCPDI Logo.png
Pediatric Accelerator.png

ALGOMETRX UPDATES

1
2
 
 

STAY IN TOUCH

Want to learn more? Want to recieve updates on AlgometRx? Please get in touch below!

Thanks for submitting!